Exelixis Inc Increase (Decrease) in Restructuring Reserve
Exelixis Inc (EXEL) reported Increase (Decrease) in Restructuring Reserve of -$927.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestructuringReserve · last filed 2016-08-03
- Exelixis Inc increase (decrease) in restructuring reserve for the quarter ending 2016-06-30 was $130.00K.
- Exelixis Inc increase (decrease) in restructuring reserve for the quarter ending 2016-03-31 was -$1.06M.
- Exelixis Inc increase (decrease) in restructuring reserve for the quarter ending 2015-12-31 was -$1.45M, a 459.55% decline year-over-year.
- Exelixis Inc increase (decrease) in restructuring reserve for the quarter ending 2015-09-30 was -$2.41M, a 908.72% decline year-over-year.
- Exelixis Inc increase (decrease) in restructuring reserve for fiscal 2015 was -$7.18M.
- Exelixis Inc increase (decrease) in restructuring reserve for fiscal 2014 was -$2.30M.
- Exelixis Inc increase (decrease) in restructuring reserve for fiscal 2013 was -$5.75M, a 209.65% decline from fiscal 2012.
- Exelixis Inc increase (decrease) in restructuring reserve for fiscal 2012 was $5.24M.
| Period end | Increase (Decrease) in Restructuring Reserve 3 month | Increase (Decrease) in Restructuring Reserve 6 month | Increase (Decrease) in Restructuring Reserve 9 month | Increase (Decrease) in Restructuring Reserve 12 month |
|---|---|---|---|---|
| 2016-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$927.00K 10-Q · filed 2016-08-03 | -$2.38M derived: sum of 3 quarters · filed 2016-08-03 | -$4.79M derived: sum of 4 quarters · filed 2016-08-03 |
| 2016-03-31 | -$1.06M 10-Q · filed 2016-05-04 | -$2.51M derived: sum of 2 quarters · filed 2016-05-04 | -$4.92M derived: sum of 3 quarters · filed 2016-05-04 | -$5.21M derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.86M derived: sum of 2 quarters · filed 2016-02-29 | -$4.16M derived: sum of 3 quarters · filed 2016-08-03 | -$7.18M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$2.71M derived: sum of 2 quarters · filed 2016-08-03 | -$5.73M 10-Q · filed 2015-11-10 | -$5.33M derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-06-30 | -$297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$3.32M 10-Q · filed 2016-08-03 | -$2.92M derived: sum of 3 quarters · filed 2016-08-03 | -$2.62M derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | -$3.02M 10-Q · filed 2016-05-04 | -$2.62M derived: sum of 2 quarters · filed 2016-05-04 | -$2.32M derived: sum of 3 quarters · filed 2016-05-04 | -$4.08M derived: sum of 4 quarters · filed 2016-05-04 |
| 2014-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $701.00K derived: sum of 2 quarters · filed 2016-02-29 | -$1.06M derived: sum of 3 quarters · filed 2016-02-29 | -$2.30M 10-K · filed 2016-02-29 |
| 2014-09-30 | $298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$1.46M derived: sum of 2 quarters · filed 2015-11-10 | -$2.71M 10-Q · filed 2015-11-10 | -$3.13M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$3.00M 10-Q · filed 2015-08-11 | -$3.43M derived: sum of 3 quarters · filed 2016-02-29 | -$5.40M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$1.24M 10-Q · filed 2015-04-30 | -$1.67M derived: sum of 2 quarters · filed 2016-02-29 | -$3.64M derived: sum of 3 quarters · filed 2016-02-29 | -$4.61M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$2.40M derived: sum of 2 quarters · filed 2016-02-29 | -$3.37M derived: sum of 3 quarters · filed 2016-02-29 | -$5.75M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$2.94M derived: sum of 2 quarters · filed 2014-11-04 | -$5.32M 10-Q · filed 2014-11-04 | |
| 2013-06-30 | -$971.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$3.35M 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | -$2.38M 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | $5.24M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | -$303.00K 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |